inherent accuracy &d applicability of the model, the measurement uncertainty for Pu in urine, the representativenes of the urine sample (e&, 24 h M. spot), individual variability, the route of entry, physicochemical form, and, perhaps most significantly in the case of chronic exposure, the time after intake used to calculate the fractional e x d o n value. Except in the case of an acute accidental exposure, the sptcific time of intake and other important parameters may not be known. The combined effects of these uncertainties may be sufficient to result in errors of an order of magnitude or greater.
for Pu have been put forth in the literature, including those ofhngham d a l . ( 1950 ( ), Healy ( 1957 , Beach and Dolphin (1%4) , Durbin (1972) , Rundo et al. (1976) , Parkinson and HenIey (1981) , Leggett (1984 Leggett ( , 1985 , Jones (1985) , and Leggett and Eckerman ( 1987) (Langham et al. 1950 This resulted in the following equation: ( 1969, 1972) , who also adapted the model for use with ICRP lung model (Nelson 1967) . The Langham data were also reevaluated by Beach and Dolphin (1964) + 0.0052e"00m0" + 0.000086e-0.0000'9' 9 (7) noting that at 10, OOO d postintake, the estimated urinary excretion would be fourfold greater than that calculated h m the Langham model, which would result in a fourfold reduction in the estimated systemic deposition. Although no d i m reference to human excretion data was made, Parkinson and Henley indicated that their model was developed from excretion data from a few exposed individuals but with some emphasis placed on Case HP-' 6, an injection case that was also used by Durbin ( 1972) )and Rundo d al. ( 1976) in their analyses. They attempted to achieve a better fit of the data with the then current ICRP model ( 1972) .
The problem of the validity of previous urinary excretion models at long times after intake was rigorously evaluated by Jones ( 1985) , who incorporated the excretion data collected by Rundo et al. (1976) at 10, OOO d postinjection to obtain a fourcomponent exponential model for urinary excretion (eqn 8) with the same general form, albeit different coefficients, as that of Parkinson and HenIey :
In a note added in proof, Jones cautioned that reconsideration of the additional data coupled with some newly available urinary excretion data at times 300-400 d postintake indicated that the model given in eqn (8) would undentate urinary excretion at 1,000-10,000 d postintake by 20-306 and correspondingly overstate uptake by the same fraction. Recently, Leggett (1984 Leggett ( , 1985 , in contrast to simply fitting equations to existing data, derived a mechanistic model for the retention and excretion of systemic Pu that was applicable to exposures at any adult age. He characterized the fractional retention R( I) [ as opposed to the percentage daily excretion, Y ( u ) ] afier injection into the bloodstream, in terms of the following explicit four-component exponential:
Since eqn ( 9 ) includes both urinary and fecal excretion, it cannot be readily convened to Y ( u ) unless the relative amounts excreted via the feces and urine are known. Once a suitable estimate ofthe urine to fecal excretion ratio has been selected, eqn ( 9 ) can be appropriately adjusted to consider only urinary excretion. Leggett, in conjunction with Eckerman (Leggett and Eckerman 1987) The lCRP has twice published comprehensive examinations of the metabolism of Pu recommending certain parameters that can be used to develop an excretion equation for Pu. In the first of these, originally put forth in I972 and reiterated in 1979 I972 and reiterated in (ICRP 1972 I972 and reiterated in , 1979 , the initial fractionation of Pu is taken as 45% to liver with a residence half-time of 40 y, 45% to skeleton with a residence half-time of 100 y, and 10% to early excretion and other tissues. Ignoring the small early excretion component, a two-companment exponential retention function for the percentage of systemic Pu remaining at time I can be derived from the lCRP parameters: Equation ( 1 I ) includes both fecal and urinary excretion, and hence some estimate of urinary excretion needs to be made in order to calculate a urinary excretion function.
Voelz ct al. ( 1979) . in their 32-y follow-up of 26 Pu exposure cases, observed that while fecal excretion at 31-32 y postexposure was variable, fecal excretion averaged about 3040% of the urinary excretion. A similar observation was made in two of the early injection cases at IO,OOOd(27.4 y)poste!xposure(Rundoet a]. 1976).These data suggest that at long times postexposure, the urinary to f d ratio is about 2. Durbin (1972) , in her analysis of human data, indicated that at times greater than 100 d postexposure, the urine to fecal excretion ratio is I .O to 1.5. At earlier times, Durbin indicates the ratio is closer to unity and perhaps even less than unity very soon after intake. Assuming the ratio of urinary to fecal excretion is more or less constant with time and equal to 1.5, Y ( u ) can be obtained by adjusting eqn Y ( u ) = 0.0029e-0.00009sr + 0.00 1 9e-0.000038' .
CASE REPORTS
Five USTR whole-body donors with a history of occupational exposure to Pu are included in this study; these cases have been briefly described elsewhere along with the initial mulu of the postmodem tissue radioanalyses for Pu (McInroy et al. 1989 More than 200 urinalyses for 239+240Pu were performed over the course of his employment. Approximately half were performed prior to 1957 and, thus, are of questionable validity. The bioassay and work history data are suggestive of long-term chronic low-level exposure, with more than half of his exposure incurred in the first few years of employment. His final urinalysis was performed in 1975, some 3 y after employment ended and more than IO y prior to death, and this measurement indicated a level of 11.5 mBq 24 h-I.
ESTIMATING SYSTEMIC DEPOSITION FROM URINARY EXCRETlON MODELS
The models discussed above can be used to estimate systemic deposition by simply dividing Y ( u ) , expressed as a fraction rather than a percent, into the Pu activity exmted on day I after intake. Mathematically, this can be expressed by: in which 90 is the initial systemic activity and A is the activity in the urine on day 1 .
The initial systemic deposition is what is typically .)
calculated for operational health physics purposes, as it not only furnishes an estimate of the immediate and t y p ically highest deposition following an intake but also meets regulatory needs and provides the basis for calculating committed dose equivalent or committed effective dose equivalent. It is not, however, the same as what is measured in the tissues after death-the socalled autopsy measurement. The autopsy results refer to what is in the body,at the time of death and thus reflects any excretion or translocation that took place between the time of intake and the time of death. Since Pu has a long residence time in the body, if the interval between intake and death is short-even as short as a few years-the amount of Pu excreted will be a relatively small fraction of the initial systemic deposition, and the initial systemic deposition and the amount remaining at the time of death will be approximately equal. However, as this interval increases, the fractional excretion also increases and could become substantial, particularly if the exposure was incurred 30
or more years prior to death. In such cases, as much as three-fourths, and possibly even more, of the original deposition might have been excreted, depending on the excretion rate from the various compartments. Thus, there could easily be a factor of four difference between the initial deposition and what remains at the time of death, despite a long residence half-time (e.g., 50 y ) in a major Consequently, it is appropriate to correct the initial deposition to account for removal from the body. This is done by integrating the excretion equation with respect to time, to obtain the fraction of the initial deposition that has been excreted, and subtracting this from the previously calculated initial deposition to determine the deposition (9,) remaining at the time of death, or, for that matter, any time selected after intake. This technique is shown mathematically as:
site of deposition such as the skeleton.
*"
( 1 5 )
"=y(u)-S in the following example in which the systemic deposition is calculated for an individual at I days after an intake of Pu. The above technique, while conceptually simple, is deceptively so, for in practice, an individual may incur multiple exposures or be chronically exposed to unknown and variable levels. Moreover, the specific day of the exposure (Le., intake), as well as its magnitude, is uncertain, and diurnal variation in urinary excretion of the individual can also affect the estimate. To minimize these potential sources of error, urinalysis data collected over a period of time is used, and they are sometimes subjected to analysis by sophisticated computer programs such as PUQFUA (Lawrence 1962 (Lawrence , 1978 Snyder 1962) , which perform multiple iterative and smoothing functions for a particular model. In this study, the calculations for each of the models listed in Table I and described The basic technique was to plot urinary excretion of Pu as a function of time, fitting the individual data points to a smoothed curve by eye. A step increase in urinary excretion was considered to be a presumption of a fresh acute systemic deposition, or, in other words, an incremental addition to the already present systemic deposition. Occupational and exposure history data were used to veri6 that an acute exposure at that time was in fact reasonable. Since the urinary excretion of Pu at approximately the time of death was known for all cases, it was relatively easy to calculate the relative contribution of each of the two or three stepfunction increases typically ob served in the urinalysis data to the urinary excretion of Pu at the time of death using the various models. Simplifying assumptions regarding the specific time and relative magnitude of exposure were made based on the available exposure and bioassay data for each case; for any given case the same assumptions were used with all models. For example, if examination of the available bioassay and other information on a case suggested a chronic low-level exposure or intake over a period of a few years, this complex intake situation was simplified by assuming that the chronic intake could be approximated by a single intake of equal magnitude occumng at a p proximately the midpoint in time of the chronic intake. Estimates made in this fashion compared very well with the more rigorous summation techniques for the chronic intake situation, which were camed out with the aid of a computer in a few select cases.
With the exception of the Healy modification to the Langham model, continuous release of activity to the blood From a deposition in the lung of Class Y material, or from activity at a wound site, was not assumed. In the one case (Case 2 12) in which chelation therapy was used following a percutaneous exposure, the period of enhanced urinary excretion of Pu was determined by eye from examination of the excretion curve. Urinalysis results during this period were not used.
RESULTS AND DISCUSSION
Estimates of initial deposition of Pu using eqn ( 14) have been made for each case using the 13 biokinetic models for Pu described above, and these are given in Table 1 . In Table 2 , the estimated syslemic deposition at the time of death, calculated with eqn ( 15), is presented for the various models except for the two with the continual release compartment. These can be compared with the postmortem measurement mults, which are also gjven in Table 2 . The two models With continual release compartments-i.e., the Hedy model and that of Beach and D o l p h i n d o not permit calculation of systemic deposition per se but rather estimate the ultimate systemic u p take from a reservoir slowly releasing Pu from the site of initial deposition to the blood. For this reason, they are not included in Table 2 .
In four cases, exposure was primarily via inhalation; in the other case (212), a contaminated wound was the primary source of exposure. Since in all cases the majority of the intdke took place many yean (typically two to three decades) prior to death, the deposition estimates with the various models at the time of death (Table 2) are for long times postexposure and accordingly are smaller than the estimates of initial deposition made with the same models ( Table 1 ) . In general, differences between the initial sysand the estimated deposition at the time of death [ r e p resented by q, in eqn ( I S ) ] do not differ appreciably for the earlier biokinetic models such as those of Langham et al. ( 1950) but do differ significantly with the later models. In other words, the later models predict greater excretion, which is, of course, as they were intended to do. This is not surprising in view of recent reports by Moss and Gautier (1985) and Moss and Tietjen (1989) , who reexamined the raw data on which the Langham model was based and observed that errors had been made that resulted in underestimation of the excretion at long times after intake, which would, of course, lead to overestimation of predictions of deposition based on the Langham model. 
